We quantified the 3 major C-terminal fragments enriched in late stage AD patients, C-LMW1, 2 and 3 (37, 30 and 23 kDa) and normalized against total C-terminal tau signal (see Methods). The gene discussed is MAPT; the disease is Alzheimer disease.